Ellington Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-800
| Closed | -$300K | – | 703 |
|
|
2019
Q4 | $300K | Sell |
800
-2,100
| -72% | -$788K | 0.06% | 287 |
|
|
2019
Q3 | $804K | Buy |
2,900
+1,700
| +142% | +$471K | 0.15% | 130 |
|
|
2019
Q2 | $376K | Buy |
+1,200
| New | +$376K | 0.06% | 281 |
|
|
2018
Q4 | – | Sell |
-2,000
| Closed | -$808K | – | 561 |
|
|
2018
Q3 | $808K | Sell |
2,000
-300
| -13% | -$121K | 0.22% | 121 |
|
|
2018
Q2 | $793K | Buy |
+2,300
| New | +$793K | 0.06% | 95 |
|
|
2016
Q1 | – | Sell |
-500
| Closed | -$271K | – | 662 |
|
|
2015
Q4 | $271K | Buy |
+500
| New | +$271K | 0.1% | 317 |
|
|
2014
Q1 | – | Sell |
-800
| Closed | -$220K | – | 737 |
|
|
2013
Q4 | $220K | Sell |
800
-1,900
| -70% | -$523K | 0.08% | 417 |
|
|
2013
Q3 | $845K | Buy |
2,700
+100
| +4% | +$31.3K | 0.16% | 153 |
|
|
2013
Q2 | $585K | Buy |
+2,600
| New | +$585K | 0.11% | 245 |
|